2 most recent filings and news items mentioning WST. Updated every 60 seconds.
Earnings|Guidance|Buyback|DividendJul 23, 2026Positive
West Pharmaceutical Services reported strong financial results for the second quarter of 2026, exceeding expectations due to robust sales growth in proprietary products. The company raised its full-year revenue and adjusted EPS guidance.
View filing at SEC.gov →
LeadershipJun 1, 2026Positive
West Pharmaceutical Services has entered into an executive employment agreement with Michel Lagarde to serve as President and CEO starting August 31, 2026, with Board appointment. The move signals leadership succession planning for the medical device packaging company.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.